GlobalData on MSN6d
AstraZeneca lung cancer therapy Imfinzi recommended for EU approval
The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended AstraZeneca's Imfinzi ...
PMLiVE7d
AstraZeneca’s Imfinzi recommended by CHMP to treat small cell lung cancer
The Committee for Medicinal Products for Human Use (CHMP) has recommended that the immunotherapy be approved to treat adults ...
Pharmabiz6d
Imfinzi recommended for approval in European Union for the treat of adults with limited-stage small cell lung cancer
Imfinzi recommended for approval in European Union for the treat of adults with limited-stage small cell lung cancer ...
AstraZeneca PLC: Imfinzi recommended for EU approval for LS-SCLC
Imfinzi recommended for approval in the EU by CHMP as first and only immunotherapy for limited-stage small cell lung cancer Recommendation based on ADRIATIC Phase III trial results which ...
London South East7d
AstraZeneca's Imfinzi endorsed for EU approval for lung cancer care
(Alliance News) - AstraZeneca PLC on Monday said Imfinzi has been recommended for approval in the EU as monotherapy for limited-stage small cell lung cancer. The Committee for Medicinal Products ...
AstraZeneca's Imfinzi set for go-ahead by EU to treat lung cancer
AstraZeneca's Imfinzi has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has ...
Pharm Exec12d
ADRIATIC Trial Demonstrates Significant Survival Benefit in LS-SCLC, Potentially Shaping Future Treatment Standards
Nancy Ghattas, VP, US franchise head, imunno-oncology, gastrointestinal tumors, AstraZeneca, discusses the promising results from the ADRIATIC trial, in which patients were treated with Imfinzi for ...